Catechin inhibits Candida albicans dimorphism by disrupting Cek1 phosphorylation and cAMP synthesis

Microbial Pathogenesis

Volumn 56, Issue , 2013, Pages 16-20

  Saito, Hideo ^a   Tamura, Muneaki ^a   Imai, Kenichi ^a   Ishigami, Tomohiko ^a   Ochiai, Kuniyasu ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

CAMP; Candida albicans; Catechin; Hypha; MAP kinase; Yeast

Indexed keywords

CATECHIN; CYCLIC AMP; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN CEK1; UNCLASSIFIED DRUG;

ANTIDIMORPHISM ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; FUNGUS HYPHAE; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CATECHIN; CYCLIC AMP; FLOW CYTOMETRY; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION;

EID: 84873470657     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2013.01.002     Document Type: Article

References (32)

1. Crespy V., Williamson G. A review of the health effects of green tea catechins in in vivo animal models. J Nutr 2004, 134:3431S-3440S.
2. Cabrera C., Artacho R., Giménez R. Beneficial effects of green tea - a review. J Am Coll Nutr 2006, 25:79-99.
3. Park B.J., Park J.C., Taguchi H., Fukushima K., Hyon S.H., Takatori K. Antifungal susceptibility of epigallocatechin 3-O-gallate (EGCg) on clinical isolates of pathogenic yeasts. Biochem Biophys Res Commun 2006, 347:401-405.
4. Eggimann P., Garbino J., Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis 2003, 3:685-702.
5. Alasio T.M., Lento P.A., Bottone E.J. Giant blastoconidia of Candida albicans. A case report and review of the literature. Arch Pathol Lab Med 2003, 127:868-871.
6. Clemons K.V., Stevens D.A. Efficacy of ravuconazole in treatment of mucosal candidosis in SCID mice. Antimicrob Agents Chemother 2001, 45:3433-3436.
7. Salerno C., Pascale M., Contaldo M., Esposito V., Busciolano M., Milillo L., et al. Candida-associated denture stomatitis. Med Oral Patol Oral Cir Bucal 2011, 16:e139-e143.
8. Sato T., Watanabe T., Mikami T., Matsumoto T. Farnesol, a morphogenetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade. Biol Pharm Bull 2004, 27:751-752.
9. Casanova M., Lopez-Ribot J.L., Martinez J.P., Sentandreu R. Characterization of cell wall proteins from yeast and mycelial cells of Candida albicans by labelling with biotin: comparison with other techniques. Infect Immun 1992, 60:4898-4906.
10. Han Y. Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism. Biol Pharm Bull 2007, 30:1693-1696.
11. Lengeler K.B., Davidson R.C., D'souza C., Harashima T., Shen W.C., Wang P., et al. Signal transduction cascades regulating fungal development and virulence. Microbiol Mol Biol Rev 2000, 64:746-785.
12. Cloutier M., Castilla R., Bolduc N., Zelada A., Martineau P., Bouillon M., et al. The two isoforms of the cAMP-dependent protein kinase catalytic subunit are involved in the control of dimorphism in the human fungal pathogen Candida albicans. Fungal Genet Biol 2003, 38:133-141.
13. Monge R.A., Román E., Nombela C., Pla J. The MAP kinase signal transduction network in Candida albicans. Microbiology 2006, 152:905-912.
14. Csank C., Schröppel K., Leberer E., Harcus D., Mohamed O., Meloche S., et al. Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis. Infect Immun 1998, 66:2713-2721.
15. Masiá C.M., Gutiérrez R.F. Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2002, 2:550-563.
16. Tamura M., Saito H., Kikuchi K., Ishigami T., Toyama Y., Takami M., et al. Antimicrobial activity of gel-entrapped catechins toward oral microorganisms. Biol Pharm Bull 2011, 34:638-643.
17. Toyoda M., Cho T., Kaminishi H., Sudoh M., Chibana H. Transcriptional profiling of the early stages of germination in Candida albicans by real-time RT-PCR. FEMS Yeast Res 2004, 5:287-296.
18. Shareck J., Nantel A., Belhumeur P. Conjugated lonoleic acid inhibits hyphal growth in Candida albicans by modulating Ras1p cellular levels and downregulating TEC1 expression. Eukaryot Cell 2011, 10:565-577.
19. Sellam A., Askew C., Epp E., Tebbji F., Mullick A., Whiteway M., et al. Role of transcription factor CaNdt80p in cell separation, hyphal growth, and virulence in Candida albicans. Eukaryot Cell 2010, 9:634-644.
20. Matsuki M., Kanatsu H., Watanabe T., Ogasawara A., Mikami T., Matsumoto T. Effects of antifungal drugs on proliferation signals in Candida albicans. Biol Pharm Bull 2006, 29:919-922.
21. Cheng G., Wozniak K., Wallig M.A., Fidel P.L., Trupin S.R., Hoyer L.L. Comparison between Candida albicans agglutinin-like sequence gene expression patterns in human clinical specimens and models of vaginal candidiasis. Infect Immun 2005, 73:1656-1663.
22. Naglik J.R., Moyes D., Makwana J., Kanzaria P., Tsichlaki E., Weindl G., et al. Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis. Microbiology 2008, 154:3266-3280.
23. Martín H., Rodríguez-Pachón J.M., Ruiz C., Nombela C., Molina M. Regulatory mechanisms for modulation of signaling through the cell integrity Slt2-mediated pathway in Saccharomyces cerevisiae. J Biol Chem 2000, 275:1511-1519.
24. Sharkey L.L., McNemar M.D., Saporito-Irwin S.M., Sypherd P.S., Fonzi W.A. HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1. J Bacteriol 1999, 181:5273-5279.
25. Rocha C.R., Schröppel K., Harcus D., Marcil A., Diqnard D., Taylor B.N., et al. Signaling through adenylyl cyclase is essential for hyphal growth and virulence in the pathogenic fungus Candida albicans. Mol Biol Cell 2001, 12:3631-3643.
26. Ene I.V., Bennett R.J. Hwp1 and related adhesins contribute to both mating and biofilm formation in Candida albicans. Eukaryot Cell 2009, 8:1909-1913.
27. Hoyer L.L., Payne T.L., Bell M., Myers A.M., Scherer S. Candida albicans ALS3 and insights into the nature of the ALS gene family. Curr Genet 1998, 33:451-459.
28. Sohn K., Urban C., Brunner H., Rupp S. EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Mol Microbiol 2003, 47:89-102.
29. Braun B.R., Johnson A.D. TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 2000, 155:57-67.
30. Chen Y.C., Wu C.C., Chung W.L., Lee F.J. Differential secretion of Sap4-6 proteins in Candida albicans during hyphae formation. Microbiology 2002, 148:3743-3754.
31. Borges-Walmsley M.I., Walmsley A.R. cAMP signalling in pathogenic fungi: control of dimorphic switching and pathogen. Trends Microbiol 2000, 8:133-141.
32. Román E., Cottier F., Ernst J.F., Pla J. Msb2 signaling mucin controls activation of Cek1 mitogen-activated protein kinase in Candida albicans. Eukaryot Cell 2009, 8:1235-1249.